CRT 2026
Atherosclerosis and Lipids
Jean-Claude Tardif, MD
Director of Research Center
Montreal Heart Institute
Montreal, Quebec, Canada
Disclosure(s): Boehringer-Ingelheim: Grant/Research Support (Ongoing); Ceapro: Grant/Research Support (Terminated); DalCor Pharmaceuticals: Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Merck: Grant/Research Support (Ongoing); Novartis: Grant/Research Support (Ongoing); Novo-Nordisk: Grant/Research Support (Ongoing); Verve Therapeutics: Grant/Research Support (Ongoing)